Pfizer – Enterprise Tech Ecosystem Series

Pfizer Inc. (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies, and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa and the Middle East. Pfizer is headquartered in New York, the US.

Disruptive technologies, advanced analytics, and supercomputing platforms have played a vital role during Pfizer COVID-19 vaccine production, helping it identify the correct drug and used throughout the trials. Pfizer adopted AI as its core technology for conducting vaccine trials, vaccine processing, and streamlining its distribution. Pfizer's prior investment in digital infrastructure, digitalization of R&D operations, and AI-enabled working systems further complemented its effort in producing and distributing the vaccine in less than a year.

The report provides information and insights into Pfizer's tech activities, including –

– Insights of its digital transformation strategies and innovation hubs and accelerator programs

– Overview of technology initiatives covering partnerships, product launches and investments

– Insights on each technology initiative including technology theme, objective, and benefits

– Details of estimated ICT budgets and major ICT contracts

Scope

– In March 2021, Pfizer partnered with Iktos, a startup specialized in development of AI solution for clinical research. The partnership enabled Pfizer to deploy Iktos’ AI-based generative modelling technology, Makya for de novo design of small molecule drugs.

– Pfizer teamed up with Saama Technologies under Pfizer's Breakthrough Change Accelerator, an incubation sandbox, to develop SDQ, an AI tool to boost the COVID-19 vaccine development process. The tool enabled Pfizer's clinical team to maintain the data quality throughout the clinical trial and reduce the patients.

– In March 2021, Pfizer initiated the establishment of its technologically enabled sterile injectable pharmaceutical production facility dubbed as Modular Aseptic Processing (MAP) in Michigan. The company intends to equip this facility with virtual reality wearables like Oculus or Google Glasses for training, robotics, and isolator-based technology.

– In February 2021, Pfizer selected Seven Bridges, a bioinformatics company, to develop a data management and collaboration platform for the company’s single-cell ribonucleic aid (RNA) sequencing (scRNASeq) data. Further, Seven Bridges offers a cloud-based environment to Pfizer for performing bioinformatic analyses and enabling the research team to store, analyze and interpret data.

– In January 2021, Pfizer teamed up with WeRobotics, a provider of robotics solutions, to design a cargo drone by adding special features to M300, an industrial drone manufactured by DJI with AI capabilities and sensors. The drone will be used to distribute COVID-19 vaccines even to the remotest communities.

Reasons to buy

– Gain insights into Pfizer's tech operations.

– Gain insights into its tech strategies and innovation initiatives.

– Gain insights into its technology themes under focus.

– Gain insights into various product launches, partnerships, and investments strategies.

Companies mentioned

Saama Technologies

Oracle

Prime Therapeutics

Flatiron Health

Syapse

Centogene

Foundation Medicine

Iktos

CytoReason

IBM

PostEra

Insilico Medicine

Catalia Health

Concerto HealthAI

Indegene

XtalPi

Atomwise

Complexica

Fitbit

Striiv

Chronicled

Sanofi

Amgen

Aimedis Healthcare

LinkLab

Gronstedt Group

vStream

Sudler Sydney

Webling Interactive

Seven Bridges

Adobe

Medallia

OpenEye

Broad Institute of MIT

Harvard

WeRobotics

Bar Ilan University Research and Development Company (BIRAD)

Iatric

American Lung Association

DDB NZ

Akili Interctaive Labs

Entrepreneurial Game Studio

Brigham and Women's Hospital

Blue Prism

Pegasystems

Simulocity

Sidekick Health

Poppit

Ochsner Health

Anthem

City of Hope

National Urban League

Jianke

Tmall Global

Nimbus Therapeutics

Adapsyn Bioscience

Advanced MR Analytics (AMRA)

System1 Biosciences

Table of Contents

Table of Contents

Overview

Digital Transformation Strategy

Innovation Hubs and Accelerator Programs

Technology Focus

Technology Initiatives

Investments

Partner – Investor Network Map

ICT Budget & Contracts

Key Executives

About GlobalData

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports